Hand transplants get a boost: new drug may reduce rejection risk
Disease control
Recruiting now
This phase 2 study tests whether a hand transplant from a deceased donor, combined with the immunosuppressant belatacept (Nulojix), can help people with below-elbow limb loss use their new hand in daily tasks. Fifty participants aged 18-65 will be followed for 18 months. The main…
Phase: PHASE2 • Sponsor: Linda Cendales • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC